Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1953 1
1954 1
1959 1
1963 1
1965 2
1966 1
1967 1
1968 4
1969 3
1970 2
1972 2
1973 1
1974 2
1975 2
1976 3
1977 3
1978 2
1979 2
1980 1
1983 3
1984 1
1986 1
1987 1
1988 2
1989 1
1994 3
1995 1
1996 2
1997 2
1998 2
1999 1
2000 1
2002 1
2004 4
2005 3
2006 2
2007 8
2008 6
2009 1
2010 3
2011 2
2012 5
2013 8
2014 6
2015 6
2016 9
2017 3
2018 6
2019 4
2020 7
2021 3
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Climate regulation processes are linked to the functional composition of plant communities in European forests, shrublands, and grasslands.
Kambach S, Attorre F, Axmanová I, Bergamini A, Biurrun I, Bonari G, Carranza ML, Chiarucci A, Chytrý M, Dengler J, Garbolino E, Golub V, Hickler T, Jandt U, Jansen J, Jiménez-Alfaro B, Karger DN, Lososová Z, Rašomavičius V, Rūsiņa S, Sieber P, Stanisci A, Thuiller W, Welk E, Zimmermann NE, Bruelheide H. Kambach S, et al. Among authors: sieber p. Glob Chang Biol. 2024 Feb;30(2):e17189. doi: 10.1111/gcb.17189. Glob Chang Biol. 2024. PMID: 38375686
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.
Abida W, Hahn AW, Shore N, Agarwal N, Sieber P, Smith MR, Dorff T, Monk P, Rettig M, Patel R, Page A, Duff M, Xu R, Wang J, Barkund S, Pankov A, Wang A, Junttila MR, Multani PS, Daemen A, Chow Maneval E, Logothetis CJ, Morris MJ. Abida W, et al. Among authors: sieber p. Clin Cancer Res. 2024 Mar 15;30(6):1111-1120. doi: 10.1158/1078-0432.CCR-23-3508. Clin Cancer Res. 2024. PMID: 38226958 Clinical Trial.
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.
De La Cerda J, Dunshee C, Gervasi L, Sieber P, Belkoff L, Tutrone R, Lu S, Gatoulis SC, Brown B, Migoya E, Shore N. De La Cerda J, et al. Among authors: sieber p. Target Oncol. 2023 May;18(3):383-390. doi: 10.1007/s11523-023-00967-5. Epub 2023 Apr 15. Target Oncol. 2023. PMID: 37060432 Free PMC article. Clinical Trial.
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Sweeney CJ, Percent IJ, Babu S, Cultrera JL, Mehlhaff BA, Goodman OB, Morris DS, Schnadig ID, Albany C, Shore ND, Sieber PR, Guba SC, Zhang W, Wacheck V, Donoho GP, Szpurka AM, Callies S, Lin BK, Bendell JC. Sweeney CJ, et al. Among authors: sieber pr. Clin Cancer Res. 2022 Jun 1;28(11):2237-2247. doi: 10.1158/1078-0432.CCR-21-2326. Clin Cancer Res. 2022. PMID: 35363301 Free PMC article. Clinical Trial.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators. Smith MR, et al. Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4. Lancet Oncol. 2022. PMID: 35131040 Free PMC article. Clinical Trial.
143 results